Cui H, Kilpeläinen T, Zouzoula L, Auno S, Trontti K, Kurvonen S, et al. Prolyl oligopeptidase inhibition reduces alpha-synuclein aggregation in a cellular model of multiple system atrophy. J Cell Mol Med. 2021;25:9634-9646 pubmed publisher

Svarcbahs R, Julku U, Norrbacka S, Myöhänen T. Removal of prolyl oligopeptidase reduces alpha-synuclein toxicity in cells and in vivo. Sci Rep. 2018;8:1552 pubmed publisher

Piltonen M, Savolainen M, Patrikainen S, Baekelandt V, Myöhänen T, Mannisto P. Comparison of motor performance, brain biochemistry and histology of two A30P ?-synuclein transgenic mouse strains. Neuroscience. 2013;231:157-68 pubmed publisher

Ye Q, van Amerongen M, Sandham J, Bank R, van Luyn M, Harmsen M. Site-specific tissue inhibitor of metalloproteinase-1 governs the matrix metalloproteinases-dependent degradation of crosslinked collagen scaffolds and is correlated with interleukin-10. J Tissue Eng Regen Med. 2011;5:264-74 pubmed publisher

Pelkonen A, Hiltunen M, Kiianmaa K, Yavich L. Stimulated dopamine overflow and alpha-synuclein expression in the nucleus accumbens core distinguish rats bred for differential ethanol preference. J Neurochem. 2010;114:1168-76 pubmed publisher

Ziolkowska B, Gieryk A, Wawrzczak Bargiela A, Krowka T, Kaminska D, Korkosz A, et al. alpha-Synuclein expression in the brain and blood during abstinence from chronic alcohol drinking in mice. Neuropharmacology. 2008;54:1239-46 pubmed publisher

Norgett E, Borthwick K, Al Lamki R, Su Y, Smith A, Karet F. V1 and V0 domains of the human H+-ATPase are linked by an interaction between the G and a subunits. J Biol Chem. 2007;282:14421-7 pubmed